| Table 2: | ||||
|
Antisecretory
Therapy for Peptic Ulcer Disease
|
||||
|
Agent
|
Duodenal
Ulcer
|
Gastric
Ulcer
|
||
|
Dose
(mg)
|
Duration
(wk)
|
Dose
(mg)
|
Duration
(wk)
|
|
| H2-receptor antagonists | ||||
| Cimetidine |
800
|
8
|
800
|
8
|
| Ranitidine |
300
|
8
|
300
|
8
|
| Famotidine |
40
|
8
|
40
|
8
|
| Nizatidine |
300
|
8
|
300
|
8
|
| Proton Pump Inhibitors | ||||
|
Esomeprazole |
20
|
4
|
40
|
8 |
| Omeprazole |
20
|
4
|
40
|
8
|
| Lansoprazole |
15
|
4
|
30
|
8
|
| Rabeprazole |
20
|
4
|
20
|
8
|
| Pantoprazole |
40
|
4
|
40
|
8
|
|
Copyright
2002 The Cleveland Clinic Foundation
|
Return to Acid Peptic Disorders Chapter